Use Options For a Chance To Buy MNTA at a 21% Discount
July 06, 2015 at 11:48 AM EDT
Looking back to 48 days ago, Momenta Pharmaceuticals Inc (MNTA) priced a 7,250,000 share secondary stock offering at $19.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 10.5% higher than the offering price..